Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection. Clin Infect Dis. 2015 May 01; 60(9):1405-14.